Table of Contents

Pharmaceutics, Volume 5, Issue 2 (June 2013), Pages 220-370

  • Issues are regarded as officially published after their release is announced to the table of contents alert mailing list.
  • You may sign up for e-mail alerts to receive table of contents of newly released issues.
  • PDF is the official format for papers published in both, html and pdf forms. To view the papers in pdf format, click on the "PDF Full-text" link, and use the free Adobe Readerexternal link to open them.
Display options:
Select articles Export citation of selected articles as:
Select/unselect all
Displaying article 1-9

Research

Jump to: Review

p. 232-245
by ,  and
Pharmaceutics 2013, 5(2), 232-245; doi:10.3390/pharmaceutics5020232
Received: 1 February 2013; in revised form: 1 April 2013 / Accepted: 10 April 2013 / Published: 17 April 2013
Show/Hide Abstract | Cited by 1 | PDF Full-text (381 KB) | HTML Full-text | XML Full-text
(This article belongs to the Special Issue Prodrugs)
abstract graphic
p. 246-260
by , , , , ,  and
Pharmaceutics 2013, 5(2), 246-260; doi:10.3390/pharmaceutics5020246
Received: 25 February 2013; in revised form: 2 April 2013 / Accepted: 12 April 2013 / Published: 23 April 2013
Show/Hide Abstract | Cited by 1 | PDF Full-text (4609 KB) | HTML Full-text | XML Full-text
(This article belongs to the Special Issue Drug Delivery Using Nanotechnology)
abstract graphic
p. 261-276
by , , , ,  and
Pharmaceutics 2013, 5(2), 261-276; doi:10.3390/pharmaceutics5020261
Received: 19 February 2013; in revised form: 26 April 2013 / Accepted: 2 May 2013 / Published: 8 May 2013
Show/Hide Abstract | Cited by 4 | PDF Full-text (353 KB) | HTML Full-text | XML Full-text
(This article belongs to the Special Issue Prodrugs)
p. 277-293
by , , , , , ,  and
Pharmaceutics 2013, 5(2), 277-293; doi:10.3390/pharmaceutics5020277
Received: 4 February 2013; in revised form: 29 April 2013 / Accepted: 3 May 2013 / Published: 10 May 2013
Show/Hide Abstract | Cited by 2 | PDF Full-text (682 KB) | HTML Full-text | XML Full-text
(This article belongs to the Special Issue Prodrugs)
p. 318-328
by , , ,  and
Pharmaceutics 2013, 5(2), 318-328; doi:10.3390/pharmaceutics5020318
Received: 21 March 2013; in revised form: 7 May 2013 / Accepted: 10 May 2013 / Published: 22 May 2013
Show/Hide Abstract | PDF Full-text (210 KB) | HTML Full-text | XML Full-text
(This article belongs to the Special Issue Prodrugs)

Review

Jump to: Research

p. 220-231
by  and
Pharmaceutics 2013, 5(2), 220-231; doi:10.3390/pharmaceutics5020220
Received: 28 February 2013; in revised form: 21 March 2013 / Accepted: 22 March 2013 / Published: 2 April 2013
Show/Hide Abstract | Cited by 1 | PDF Full-text (417 KB) | HTML Full-text | XML Full-text
(This article belongs to the Special Issue Prodrugs)
p. 294-317
by , , ,  and
Pharmaceutics 2013, 5(2), 294-317; doi:10.3390/pharmaceutics5020294
Received: 24 December 2012; in revised form: 15 April 2013 / Accepted: 3 May 2013 / Published: 15 May 2013
Show/Hide Abstract | Cited by 2 | PDF Full-text (1014 KB) | HTML Full-text | XML Full-text
(This article belongs to the Special Issue Drug Delivery Using Nanotechnology)
p. 329-352
by ,  and
Pharmaceutics 2013, 5(2), 329-352; doi:10.3390/pharmaceutics5020329
Received: 22 January 2013; in revised form: 9 May 2013 / Accepted: 16 May 2013 / Published: 27 May 2013
Show/Hide Abstract | Cited by 5 | PDF Full-text (345 KB) | HTML Full-text | XML Full-text
(This article belongs to the Special Issue Micellar Drug Delivery)
p. 353-370
by , ,  and
Pharmaceutics 2013, 5(2), 353-370; doi:10.3390/pharmaceutics5020353
Received: 22 February 2013; in revised form: 16 May 2013 / Accepted: 24 May 2013 / Published: 18 June 2013
Show/Hide Abstract | PDF Full-text (381 KB) | HTML Full-text | XML Full-text
(This article belongs to the Special Issue Drug Delivery Using Nanotechnology)
Select/unselect all
Displaying article 1-9
Select articles Export citation of selected articles as:
Pharmaceutics EISSN 1999-4923 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert